Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

v3.20.1
Segment Disclosures
 3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Segment Disclosures Segment Disclosures
 
The Company has two reportable segments: EksoHealth (also referred to as the medical devices segment) and EksoWorks (also referred to as the industrial devices segment). The EksoHealth segment designs, engineers, manufactures, and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and sells exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The reportable segments are each managed separately because they serve distinct markets.
 
The Company evaluates performance and allocates resources based on segment gross profit margin. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.
 
Segment reporting information is as follows:
  EksoHealth EksoWorks Total
Three months ended March 31, 2020      
Revenue $ 1,191    $ 277    $ 1,468   
Cost of revenue 618    213    831   
Gross profit $ 573    $ 64    $ 637   
Three months ended March 31, 2019      
Revenue $ 2,814    $ 802    $ 3,616   
Cost of revenue 1,300    717    2,017   
Gross profit $ 1,514    $ 85    $ 1,599   

Geographic information for revenue based on location of customers is as follows:
  Three Months Ended March 31,
  2020 2019
United States $ 1,249    $ 2,371   
All Other 219    1,245   
  $ 1,468    $ 3,616